Table 2 Summary of clinical studies of drugs for the treatment of Sturge-Weber syndrome secondary glaucoma
From: Sturge-Weber syndrome secondary glaucoma: From Pathogenesis to Treatment
Drug | Author | Number of eyes involved | Follow-up (months) | Result |
|---|---|---|---|---|
Propranolol | Wygnanski-Jaffe et al. [60] | 4 | 3 | One patient successfully controlled (a temporary hypotensive effect after one week) |
Latanoprost | Ong et al. [67] Altuna et al. [72] | 14 18 | 12 6 | 50% successfully controlled 16.7% (3/18) successfully controlled |
Netarsudil | Kaufman et al. [75] | 6 | 25 | Average IOP reduced by about 30% |